Wesley Miller, MD

Distinguished Teaching Professor of Medicine (Emeritus), Division of General Internal Medicine

Wesley Miller

Contact Info

Distinguished Teaching Professor of Medicine (Emeritus), Division of General Internal Medicine

Division of Hematology, Oncology and Transplantation


University of Illinois College of Medicine

University of Minnesota

University of Minnesota


Dr. Miller attended Macalester College and earned his M.D. from the University of Illinois. He returned to the University of Minnesota for his residency in Internal Medicine followed by his fellowship in Hematology. He has spent many years on the faculty as a hematologist and bone marrow transplant physician. His love of teaching led him to invest much time in education of students, residents, and faculty. He maintains strong expertise in blood diseases and cancers. His other special interests are in medical education and in evidence-based medicine and medical decision-making (the rigorous application of all data and systems resources to doing the best for each patient and populations of patients).

Awards & Recognition

  • Teacher of the Year, Internal Medicine Residents, 1994, 1999
  • Letter of Commendation for teaching, Year 2 students, 1994, 1995
  • MMF Outstanding Teacher Award 1996
  • MMF Distinguished Teaching Award, Year 3 & 4, 1997, 1998
  • MMF Distinguished Teaching Award, Year 2 students, 1999
  • All University Award for Outstanding Contributions to Graduate, Post-graduate, and Professional Education, 2000
  • Academy of Medical Educators, U of Minnesota, 2000
  • Academy of Distinguished Teachers, U of Minnesota, 2000
  • Fellow, American College of Physicians 2002
  • Medical School Graduation Greeter (elected by students), 2001, 2002, 2003, 2005
  • Glaser Award Nominee, (national AOA award for faculty) 2005
  • AOA Induction Ceremony Keynote Speaker, 2006, 2008



  • Cragg L. Blazar BR. Defor T. Kolatker N. Miller W. Kersey J. Ramsay M. McGlave P. Filipovich A. Weisdorf D. A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease. Biology of Blood & Marrow Transplantation. 6:441-7, 2000.
  • Arora M. Wagner JE. Davies SM. Blazar BR. Defor T. Enright H. Miller WJ. Weisdorf DF. Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease. Biology of Blood & Marrow Transplantation. 7(5):265-73, 2001.
  • Burns LJ. Miller W. Kandaswamy C. DeFor TE. MacMillan ML. Van Burik JA. Weisdorf DJ. Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation. [Clinical Trial. Journal Article. Randomized Controlled Trial] Bone Marrow Transplantation. 30(12):945-51, 2002.
  • Arora M. Burns LJ. Davies SM. Macmillan ML. Defor TE. Miller WJ. Weisdorf DJ. Chronic graft-versus-host disease: a prospective cohort study. [Journal Article] Biology of Blood & Marrow Transplantation. 9(1):38-45, 2003.
  • Nixon LJ. Benson BJ. Rogers TB. Sick BT. Miller WJ. Effects of Accreditation Council for Graduate Medical Education work hour restrictions on medical student experience. Journal of General Internal Medicine. 22(7):937-41, 2007.